Comprehensive Gene Expression Meta-analysis and Integrated Bioinformatic Approaches Reveal Shared Signatures Between Thrombosis and Myeloproliferative Disorders

Overview

Journal Sci Rep

Specialty Science

Date 2016 Nov 29

PMID 27892526

Citations 14

Authors

Prabhash Kumar Jha

Aatira Vijay

Anita Sahu

Mohammad Zahid Ashraf

Affiliations

Soon will be listed here.

Abstract

Thrombosis is a leading cause of morbidity and mortality in patients with myeloproliferative disorders (MPDs), particularly polycythemia vera (PV) and essential thrombocythemia (ET). Despite the attempts to establish a link between them, the shared biological mechanisms are yet to be characterized. An integrated gene expression meta-analysis of five independent publicly available microarray data of the three diseases was conducted to identify shared gene expression signatures and overlapping biological processes. Using INMEX bioinformatic tool, based on combined Effect Size (ES) approaches, we identified a total of 1,157 differentially expressed genes (DEGs) (697 overexpressed and 460 underexpressed genes) shared between the three diseases. EnrichR tool's rich library was used for comprehensive functional enrichment and pathway analysis which revealed "mRNA Splicing" and "SUMO E3 ligases SUMOylate target proteins" among the most enriched terms. Network based meta-analysis identified MYC and FN1 to be the most highly ranked hub genes. Our results reveal that the alterations in biomarkers of the coagulation cascade like F2R, PROS1, SELPLG and ITGB2 were common between the three diseases. Interestingly, the study has generated a novel database of candidate genetic markers, pathways and transcription factors shared between thrombosis and MPDs, which might aid in the development of prognostic therapeutic biomarkers.

Citing Articles

Transcriptome meta-analysis and validation to discovery of hub genes and pathways in focal and segmental glomerulosclerosis.

Roointan A, Ghaeidamini M, Yavari P, Naimi A, Gheisari Y, Gholaminejad A BMC Nephrol. 2024; 25(1):293.

PMID: 39232654 PMC: 11375834. DOI: 10.1186/s12882-024-03734-4.

A Meta-analysis of Transcriptome Data to Investigate the Effect of Soy Isoflavones on Breast Cancer Cell.

Ashrafi-Dehkordi E, Tahmasebi A, Zare H, Mazloomi S Iran J Biotechnol. 2024; 22(2):e3762.

PMID: 39220340 PMC: 11364926. DOI: 10.30498/ijb.2024.407148.3762.

In silico exploration of anti-prostate cancer compounds from differential expressed genes.

Ajiboye B, Fatoki T, Akinola O, Ajeigbe K, Bamisaye A, Dominguez-Martin E BMC Urol. 2024; 24(1):138.

PMID: 38956591 PMC: 11221101. DOI: 10.1186/s12894-024-01521-9.

Molecular crosstalk between COVID-19 and Alzheimer's disease using microarray and RNA-seq datasets: A system biology approach.

Premkumar T, Sajitha Lulu S Front Med (Lausanne). 2023; 10:1151046.

PMID: 37359008 PMC: 10286240. DOI: 10.3389/fmed.2023.1151046.

Meta-analysis based gene expression profiling reveals functional genes in ovarian cancer.

Zhao L, Li Y, Zhang Z, Zou J, Li J, Wei R Biosci Rep. 2020; 40(11).

PMID: 33135729 PMC: 7677829. DOI: 10.1042/BSR20202911.

References

Smalberg J, Arends L, Valla D, Kiladjian J, Janssen H, Leebeek F . Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012; 120(25):4921-8. DOI: 10.1182/blood-2011-09-376517. View

Spivak J, Considine M, Williams D, Talbot Jr C, Rogers O, Moliterno A . Two clinical phenotypes in polycythemia vera. N Engl J Med. 2014; 371(9):808-17. PMC: 4211877. DOI: 10.1056/NEJMoa1403141. View

Han J, Bertin N, Hao T, Goldberg D, Berriz G, Zhang L . Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature. 2004; 430(6995):88-93. DOI: 10.1038/nature02555. View

Maurer L, Tomasini-Johansson B, Mosher D . Emerging roles of fibronectin in thrombosis. Thromb Res. 2010; 125(4):287-91. PMC: 2877496. DOI: 10.1016/j.thromres.2009.12.017. View

Slonim D, Yanai I . Getting started in gene expression microarray analysis. PLoS Comput Biol. 2009; 5(10):e1000543. PMC: 2762517. DOI: 10.1371/journal.pcbi.1000543. View

Cho J, Mosher D . Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost. 2006; 4(7):1461-9. DOI: 10.1111/j.1538-7836.2006.01943.x. View

Lewis D, Stashenko G, Akay O, Price L, Owzar K, Ginsburg G . Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism. Thromb Res. 2011; 128(6):536-40. PMC: 3726737. DOI: 10.1016/j.thromres.2011.06.003. View

Hasstedt S, Bezemer I, Callas P, Vossen C, Trotman W, Hebbel R . Cell adhesion molecule 1: a novel risk factor for venous thrombosis. Blood. 2009; 114(14):3084-91. PMC: 2756210. DOI: 10.1182/blood-2009-05-219485. View

Falanga A, Marchetti M, Evangelista V, Vignoli A, Licini M, Balicco M . Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood. 2000; 96(13):4261-6. View

10.

Cerquozzi S, Tefferi A . Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J. 2015; 5:e366. PMC: 4670948. DOI: 10.1038/bcj.2015.95. View

11.

Medved L, Nieuwenhuizen W . Molecular mechanisms of initiation of fibrinolysis by fibrin. Thromb Haemost. 2003; 89(3):409-19. View

12.

cokic V, Mossuz P, Han J, Socoro N, Beleslin-Cokic B, Mitrovic O . Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway. PLoS One. 2015; 10(8):e0135463. PMC: 4537205. DOI: 10.1371/journal.pone.0135463. View

13.

Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A . ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009; 25(8):1091-3. PMC: 2666812. DOI: 10.1093/bioinformatics/btp101. View

14.

Levine R, Gilliland D . Myeloproliferative disorders. Blood. 2008; 112(6):2190-8. PMC: 2962533. DOI: 10.1182/blood-2008-03-077966. View

15.

Johnson W, Li C, Rabinovic A . Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2006; 8(1):118-27. DOI: 10.1093/biostatistics/kxj037. View

16.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

17.

Marot G, Foulley J, Mayer C, Jaffrezic F . Moderated effect size and P-value combinations for microarray meta-analyses. Bioinformatics. 2009; 25(20):2692-9. DOI: 10.1093/bioinformatics/btp444. View

18.

Adam F, Kauskot A, Rosa J, Bryckaert M . Mitogen-activated protein kinases in hemostasis and thrombosis. J Thromb Haemost. 2008; 6(12):2007-16. DOI: 10.1111/j.1538-7836.2008.03169.x. View

19.

Goerttler P, Kreutz C, Donauer J, Faller D, Maiwald T, Marz E . Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2. Br J Haematol. 2005; 129(1):138-50. DOI: 10.1111/j.1365-2141.2005.05416.x. View

20.

Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128. PMC: 3637064. DOI: 10.1186/1471-2105-14-128. View